High-Octane Stocks: Investors’ Top Picks
Discover the latest High-Octane Stocks that are making waves in the market. Stay ahead with expert insights, trending stock picks, and actionable analysis. Whether you’re a seasoned investor or just starting, our High-Octane Stocks section highlights opportunities with high growth potential and market momentum.
⚡ Key Traits of a “High-Octane” Stock
- Volatile / news-driven — reacts quickly to geopolitical or industry news
- Catalyst-driven — earnings, contracts, deals, or legislation can move it fast
- Small to mid-cap or niche market exposure — can spike on investor interest
- High retail or social media buzz — often traded by momentum traders
Today Friday, March 20, 2026, the market is being defined by “High Octane” movers—stocks with extreme price swings, high trading volume, and massive speculative interest. These are the names dominating the “viral” conversation on trading floors and social media right now.
Tevogen Bio Holdings Inc (TVGN): $5.22 USD, -1.69% (-$0.09 USD), Biotechnology. The stock remains under heavy pressure following a 1-for-50 reverse split in early March 2026, a move often viewed by the market as a last-ditch effort to maintain NASDAQ listing requirements. While the company recently highlighted advancements in its “Tevogen.AI” platform for predictive T-cell therapy, persistent liquidity concerns and a significant shareholders’ deficit continue to weigh on valuation. Despite a recent “Buy” rating from Boral Capital, the price target was slashed from $5.00 to $2.00, reflecting the steep uphill battle for this micro-cap clinical-stage player.
AppLovin Corp (APP): $477.39 USD, -7.70% (-$39.84 USD), Software/AdTech. The stock tumbled as the “SaaSpocalypse” sell-off hit high-multiple software names. Investors are growing wary that the shift toward agentic AI search could disrupt traditional app-referral economics. Despite APP’s strong execution, the technical breakdown below key support levels reflects a broader rotation into hardware.
Allurion Technologies (ALUR): $0.34 USD, -55.30% (-$0.42 USD), Healthcare/MedTech. Shares collapsed to a record low following a massive downward revision to 2026 revenue guidance. The company’s pivot to a “GLP-1 companion” model failed to convince the market, leading to a liquidity-driven sell-off. With a shrinking cash runway, the stock is now facing potential delisting risks.
Guardforce AI Co Ltd (GFAI): $0.59 USD, -3.38% (-$0.02 USD), Technology/Robotics. The stock drifted lower amid light volume as it struggles to regain the $1.00 compliance threshold. While the company is expanding its robot-as-a-service (RaaS) footprint in Asia, persistent net losses and dilution concerns continue to weigh on sentiment.
Peraso Inc (NASDAQ: PRSO): This is a high-frequency surge in the defense-tech sector, currently a parabolic arena after a massive 151.54% explosion on Friday. The “octane” is pressurized by a military catalyst: its 60 GHz mmWave semiconductor tech was just selected for a next-gen drone “Identification Friend or Foe” (IFF) system. Trading at $2.04, the stock is a high-velocity momentum play where any escalation in electronic warfare needs could propel it toward the $3.00 resistance, though its micro-cap nature makes it vulnerable to a “liquidation pullback” if the initial hype cools.
Decent Holding Inc (NASDAQ: DXST): This is a speculative micro-cap “moonshot,” currently a retail-driven battleground after an 84.26% vertical leap. The “octane” is fueled by a dual-threat catalyst: a fiscal 2025 sales boost and the launch of a new AI-powered senior care platform targeting China’s $4 trillion “silver economy.” Sitting at $0.28, the stock is a high-stakes arena with a massive 595 million share trading volume; it is a coiled spring that could gap up on further expansion news, but its history of volatility risks a “flash crash” toward the $0.15 support floor.
Edesa Biotech Inc (NASDAQ: EDSA): The ultimate “biotech gamble,” this stock is currently a scorched-earth arena after an 80.61% spike that caught the entire market off guard. The “octane” is pressurized by additional Phase 3 data for paridiprubart, showing a statistically significant 27% reduction in mortality for ARDS patients. Trading at $6.52, it is a high-velocity environment where volume has reached a staggering 160x its daily average; any follow-up regulatory chatter could ignite a move into double digits, while the massive “gap” below risks a swift retreat back toward $4.50.
AN2 Therapeutics Inc (NASDAQ: ANTX): This is a clinical-stage “volatility trap,” currently a momentum-heavy battlefield after a 66.67% rally on Friday. The “octane” is driven by a pivot into Phase 2 trials for its oral drug epetraborole, targeting polycythemia vera (PV), after a prior Phase 3 pause for a different indication. Sitting at $2.85, it is a high-velocity arena where shorts are being squeezed out by the new “value inflection point” narrative; a break above $3.00 could spark a secondary run, but the constant threat of a dilutive capital raise looms over the $2.00 support level.
Silynxcom Ltd (NASDAQ: SYNX): This is a “tactical” momentum runner, currently a high-heat battleground after a 58.00% surge on Friday. The “octane” is fueled by its niche position in military-grade communication headsets, which is seeing a speculative bid as investors hunt for “pure play” defense contracts similar to Peraso’s. Trading at $1.58, the stock is in a high-velocity zone where retail traders are chasing the “next big contract” rumor; if the volume holds through Monday morning, it could challenge its 52-week highs, but any cooling of geopolitical headlines risks a total “fade” back to $1.20.
ProShares UltraPro QQQ (NASDAQ: TQQQ): The high-performance engine of the Nasdaq-100, TQQQ stalled out with a 4.54% drop as mega-cap tech growth faced its toughest week of 2026. With Amazon battling platform outages and data center security fears, the “octane” here is fueled by concentrated exposure to the “Magnificent Seven,” which are currently being treated as source of funds for safety trades. Sitting at $47.54, the fund is a coiled spring; a Monday morning stabilization in tech could see it gap up toward its 50-day moving average, but a breach of Friday’s lows would signal a “regime shift” toward a deeper correction for the tech-heavy index.
MicroStrategy Inc (NASDAQ: MSTR): Often called the “Bitcoin proxy on steroids,” MSTR bled out 4.49% to close at $133.53 as Bitcoin struggled to hold the $72,000 level. The “octane” in MSTR comes from its dual-threat identity: it is simultaneously a high-leverage bet on crypto and an emerging “AI Software” play, making its intraday swings twice as violent as the broader market. With an implied volatility ranking in the top 90th percentile, MSTR is a lightning rod for speculators; any weekend bounce in BTC could trigger a massive short-squeeze at Monday’s open, while a break below $130 would likely trigger a cascade of technical sell-stops.
Direxion Daily Semiconductor Bull 3X Shares (NASDAQ: SOXL): This is the ultimate “triple-shot” of volatility for chip traders, currently a scorched-earth battleground after a brutal 14.88% plunge yesterday. The “octane” is pressurized by its 3x leverage on the SOX index, which is reeling from Micron’s energy-price fears and the high-stakes lead-up to Broadcom’s earnings this afternoon. Trading at $53.42, it is a high-velocity arena where a Broadcom “beat” could ignite a 25%+ recovery rally, while any further geopolitical escalation risks a total “liquidation event” toward the $40 support floor.
GE Vernova Inc. (NYSE: GEV): The engine of the AI power trade is currently a high-velocity battleground trading near $842.52. While it hit an all-time high of $894.93 just last week, the stock is currently in a “cooling phase” (-4.4% yesterday). The “octane” is fueled by a massive $22.2 billion order surge and upgraded 2026 revenue guidance of $45 billion. It is a high-stakes arena where bulls are eyeing a valuation target of $1,735, but execution risks in its wind segment remain a “fuel leak” that could spark a retreat to the $780 support level.
RTX Corporation (NYSE: RTX): This defense titan is currently the “geopolitical volatility king,” trading at $206.52 after hitting all-time highs on Monday. The “octane” is pressurized by an escalating Middle East conflict and a record $268 billion backlog. With new DARPA contracts for long-range sensing, the stock is a high-stakes bull arena targeting $238. However, after a 63% run in the past year, it’s vulnerable to a “profit-taking” flash crash toward $185 if diplomatic efforts show any signs of life.
CoreWeave Inc. (NASDAQ: CRWV): Since its 2025 IPO, the “neocloud” titan has become a volatility magnet, currently trading near $90.00. The “octane” is fueled by a $56 billion revenue backlog and a newly strengthened collaboration with NVIDIA to build “AI Factories.” Despite the growth, it is a high-stakes arena for risk-takers; an ongoing class-action lawsuit and massive CapEx debt have kept the stock 50% below its 52-week high, making every earnings update a “make-or-break” event for the $150 bull case.
MicroVision, Inc. (NASDAQ: MVIS): This LIDAR and AR developer is a “high-volatility bio-hazard” today as it reports Q4 earnings before the bell. The “octane” is nuclear-grade, fueled by a massive 22.2% short interest and a 14.7 days-to-cover ratio, making it the primary short-squeeze candidate of March. With a binary catalyst on the line, the stock is a high-stakes arena where a surprise contract win could trigger a parabolic squeeze toward $10, while a cash-burn disappointment risks a “flush-out” crash to its $1.50 penny-stock basement.
iShares MSCI Brazil ETF (NYSEARCA: EWZ): While usually a “boring” index fund, EWZ has turned into a high-octane macro play, cratering 4.71% in a single session. The “octane” comes from the “Stagflation Shock”—rising energy costs and a plummeting Real (BRL) as global capital flees emerging markets for safe havens. It is a high-stakes battleground for “carry-trade” liquidations; if the $35 support snaps, it could trigger a systemic “stop-loss” cascade as institutional algorithms exit Latin American positions en masse.
Rocket Lab USA, Inc. (NASDAQ: RKLB): This end-to-end space systems leader is currently a “high-velocity battleground,” having surged over 230% in the past year before hitting a volatile patch this morning. Trading at $69.10 as of the March 2 market open, the “octane” is fueled by a massive 73% year-over-year backlog surge and its newly minted status as a top-tier defense prime with a $515 million SDA satellite contract. With a premium 60x forward P/E (2031 target) and record 2025 revenue of $602 million, it is a high-stakes arena where $120 is the next institutional bull target, while the “Neutron slip” to Q4 2026 following a Stage 1 tank failure risks a sharp “flash crash” toward the $55 support level if execution on the heavy-lift program falters again.
Ondas Holdings Inc. (NASDAQ: ONDS): This autonomous drone and private wireless specialist is currently a “geopolitical volatility king,” having surged over 1,800% from its 52-week lows. Trading at $11.38 as of March 2, 2026, the “octane” is fueled by a $65.3 million backlog surge and massive defense contract wins with NATO and German Police for its Sentrycs counter-drone systems. With a stretched 31x P/S multiple and a recently raised $180M revenue outlook, it remains a high-stakes battleground where $25 is the next consensus bull target, while the heavy reliance on capital raises and a $52M debt load risks a sharp “flash crash” if integration of its aggressive M&A spree falters.
TechCreate Group Ltd (NYSE American: TCGL): This payment-tech specialist is currently the market’s “volatility king,” having surged over 3,400% from its $4 IPO price. Trading at $172.84 as of February 26, 2026, the “octane” is fueled by a low-float supply and its AI-RTE payments engine. With an astronomical 650x P/S multiple, it is a high-stakes battleground where $200 is the next bull target, while the lack of fundamental news risks a sharp “flash crash” toward double digits.
Cava Group Inc (NYSE: CAVA): The Mediterranean fast-casual leader gapped up +26% today, February 26, 2026, igniting a violent short squeeze that sliced through the $80 psychological resistance. The move was triggered by Q4 guidance that defied a sluggish consumer narrative, posting same-store sales growth of +0.5% against a projected decline. With a significant portion of the float previously held by shorts, the “octane” here is purely mechanical—large funds are being caught offside as the company guides for even stronger 2026 traffic.
SoundHound AI, Inc. (NASDAQ: SOUN): This voice-AI pioneer has become a primary battleground for investors betting on the “agentic AI” shift. As of February 2026, the stock is locked in a high-stakes standoff with a massive 32.54% short interest and a consensus fair value estimate near $16.31—implying over 100% upside according to bulls. With a market cap of $3.1 billion and a billion-dollar contract backlog, the “octane” is fueled by the rapid conversion of these bookings into revenue. All eyes are on the February 26, 2026, earnings call, where a beat on margins could trigger a massive short squeeze, while any sign of further cash burn risks a sharp retreat toward its $11.50 bear-case floor.
Plug Power Inc. (NASDAQ: PLUG): A perennial favorite for volatility traders, Plug Power is currently weathering a perfect storm of regulatory scrutiny and extreme speculative pressure. With short interest surging to 26.6% as of late February 2026, the stock is being hammered by a combination of shareholder dilution fears and a series of class-action lawsuits filed early this month regarding Department of Energy loan disclosures. Trading near €1.89 ($2.05 USD), the stock’s “high-octane” status is maintained by a polarized analyst field: targets range from a bearish $0.75 to a hyper-bullish $7.00. The imminent catalyst is a high-stakes shareholder vote on authorized share capital, a move that will determine if the company can bridge its $2 billion annual loss or face a liquidity crunch by mid-year.
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA): This “cell programming” giant is currently testing the limits of investor patience and AI integration. Its stock is defined by a high-beta profile (1.99x) and a recent surge in momentum following the February 5, 2026, announcement that its autonomous lab—driven by OpenAI’s GPT-5—achieved a 40% cost reduction in protein synthesis. Despite this technical breakthrough, the stock remains a high-octane gamble with a market cap of $530 million and a 52-week range of $5.00–$17.58. With Q4 earnings scheduled for February 26, 2026, the stock is a “make-or-break” play; bulls are looking for GPT-5 to finally turn their platform’s massive data moats into positive EBITDA, while bears point to a trailing interest coverage of -4896x as a sign of impending structural risk.
Intellia Therapeutics Inc. (NASDAQ: NTLA) This clinical-stage genome editing leader is the primary vehicle for investors betting on the transition of CRISPR-Cas9 technology from “science experiment” to commercial reality. Its stock is defined by extreme high-octane volatility and a fierce tug-of-war between short-sellers—holding a massive 37.9% short interest—and institutional bulls like Cathie Wood’s ARK Invest, which maintains a 12.27% stake as of February 2026. With a market capitalization of approximately $1.3 billion and a 52-week range of $5.90–$28.25, $NTLA represents an aggressive speculative play. Momentum is currently driven by the January 27, 2026 FDA decision to lift a clinical hold on its Phase 3 MAGNITUDE-2 trial. Further signaling its shift toward commercialization, the company reported on February 6, 2026, that it awarded inducement grants (RSUs for 30,600 shares) to six new employees under Nasdaq Listing Rule 5635(c)(4), a move typical for scaling operations ahead of pivotal data. This sets the stage for a high-stakes mid-2026 data readout that could trigger a historic gamma squeeze.
FintechWerx International Software Services Inc. (CSE: WERX) This Canadian financial technology provider specializes in e-commerce onboarding and payment orchestration. Its stock is defined by extreme, high-octane volatility and significant retail momentum, evidenced by a 15% price jump on January 30, 2026, following the announcement of a successful AI-driven “proof of concept” deployment. With a micro-cap valuation of approximately $62 million and a history of massive price swings—including a 4,960% return over the past year—it represents an aggressive speculative vehicle for traders betting on the commercialization of its “AI-Werx” ecosystem.
Phoenix Asia Holdings Ltd (NASDAQ: PHOE) This Hong Kong-based industrial contractor specializes in foundation and substructure construction projects. Its stock is defined by extreme, high-octane volatility, evidenced by a massive single-day price explosion of 997.44% on January 30, 2026, closing at $133.12. With a valuation that surged to over $2.88 billion on trading volume 66 times its average, it represents an exceptionally high-risk speculative vehicle, though it experienced an immediate after-hours correction of over 60% as the initial rally cooled.
Brand Engagement Network (NASDAQ: BNAI)
This small-cap AI technology services company saw its stock price explode by over 276% in one day’s trading, driven by high relative volume and speculative interest in the AI sector. Its low market capitalization and massive daily volatility make it an extremely high-risk, high-reward trading opportunity.
Iovance Biotherapeutics (NASDAQ: IOVA)
This clinical-stage biotech company is highly volatile, currently sitting on a high short interest list. Its stock price fluctuates heavily based on clinical trial results and FDA news regarding its cancer treatments, offering a classic high-risk, news-driven profile for speculative investors
San Lorenzo Gold Corp. (TSXV: SLG.V)
A junior gold exploration company on the TSX Venture exchange, its stock soared over 68% in a single day as gold prices hit record levels. High-volatility junior mining stocks like this can generate significant returns when commodity prices spike, but carry substantial risk related to exploration success and market sentiment.
AbCellera Biologics (NASDAQ: ABCL)
AbCellera uses AI and advanced lab techniques to discover new antibodies for treating diseases. It has several drugs in clinical trials and works with big pharmaceutical companies. The stock can move up or down quickly based on news, making it a high-risk, high-reward choice for investors.
Absci Corporation (NASDAQ: ABSI)
Absci designs brand-new antibodies and proteins using AI, speeding up the process from discovery to potential treatments. Because it is a smaller company, the stock can be very volatile. If its new drugs or partnerships succeed, it could grow a lot, but it comes with higher risk.
Recursion Pharmaceuticals (NASDAQ: RXRX)
Recursion uses AI, automation, and computer models to find new antibody therapies faster. Its purchase of Exscientia strengthens its AI tools. Investors may see big gains if its research succeeds, but the stock can drop if trials or approvals face delays.
Schrödinger, Inc. (NASDAQ: SDGR)
Schrödinger provides software for drug and antibody design, helping pharma companies create better medicines faster. It’s less risky than small biotech startups but still offers growth potential because more companies are using AI in research.
BioNTech SE (NASDAQ: BNTX)
BioNTech uses AI in its mRNA and antibody research to improve vaccines and treatments. It’s a bigger company with proven products, so it’s less risky than small startups, but still benefits from AI-driven innovation. The stock reacts to news about clinical results and approvals.
SLB Ltd. (SLB)
SLB is a global leader in oilfield services and energy technology, gaining attention due to rising Arctic exploration and offshore drilling demand linked to what happens if Trump takes Greenland. The stock shows a bullish trend, making it a momentum play for energy-focused investors.
Greenland Resources Inc. (GRI)
Greenland Resources is one of the few companies offering direct exposure to Greenland’s molybdenum and critical minerals projects. With regulatory momentum and Arctic development potential, the stock is attracting speculative interest from investors seeking early exposure to mining opportunities.
Saab AB (SAABF)
Saab AB is a defense and aerospace company specializing in surveillance, radar systems, and military aircraft. Geopolitical focus on Greenland’s Arctic region has increased demand for advanced defense capabilities, giving the stock strong bullish potential for strategic investors.
Rheinmetall AG (RNMBF)
Rheinmetall AG develops armored vehicles, ammunition, and military technology. Heightened Arctic and global security concerns are driving investor attention, positioning the stock as a high-octane play in the defense sector.
Nebius Group N.V. (NBIS)
Nebius is one of the strongest stocks recently, drawing attention due to a $17.5B deal with Microsoft and AI infrastructure growth forecasts. The stock shows a bullish trend, making it a momentum play for aggressive investors.
Regencell Bioscience (NASDAQ: RGC)
$52.88, +60.10%, Healthcare / Speculative Biotech
A high-volatility low-float stock. Heavy insider ownership and tiny float cause wild swings. Retail traders chase a potential short squeeze despite DOJ investigation warnings.
Gladstone Land (NASDAQ: LAND)
Steady farmland investment with rental income, focusing on fruits, vegetables, and permanent crops. A resilient, inflation-proof stock aligned with long-term value.
Strive, Inc. (NASDAQ: ASST)
Corporate Bitcoin treasury and asset manager. Accumulates Bitcoin to grow shareholder value. High volatility tied to crypto performance.
Vertiv Holdings Co (NYSE: VRT)
Leader in critical digital infrastructure for data centers and AI hardware. High-demand liquid-to-chip cooling solutions drive growth amid AI expansion.
Nickel Industries (ASX)
Nickel mining and processing focused on EV battery supply. Strategic partnerships with aerospace companies support high-growth outlook.
Innodata Inc. (NASDAQ: INOD)
AI data engineering company providing high-quality data for LLMs. High-growth play with strong projected earnings in 2026.
SkyWater Technology (NASDAQ: SKYT)
Semiconductor foundry specializing in defense and quantum computing. Small-cap potential for explosive moves with major contracts.
Aehr Test Systems (NASDAQ: AEHR)
Chip testing equipment for AI and EV markets. Highly volatile, with massive upside if major contracts materialize.
Made Tech Group (LSE: MTEC)
UK micro-cap, government AI and cloud solutions. High-risk, high-potential returns.
American Battery Technology (NASDAQ: ABAT)
Battery metals recycling for EV and grid infrastructure. Low-cap, high-octane energy play.
Lam Research (NASDAQ: LRCX)
Semiconductor equipment supplier for AI chips. Beneficiary of AI infrastructure demand with cyclical but high-upside potential.
ACM Research (NASDAQ: ACMR)
Advanced wafer cleaning for semiconductor manufacturing. High volatility but essential niche position.
Seagate Technology (STX)
High-capacity storage leader with premium HAMR drives. Record margins and AI-focused demand.
Western Digital (WDC)
Transformed HDD/Flash business, benefiting from consumer and enterprise demand. Nasdaq-100 inclusion drives momentum.
Bleichroeder Acquisition Corp. I (BACQ)
SPAC with rising volume; value tied to cash per share and potential mergers.
CME Group (CME)
Global derivatives exchange with steady growth, high profit margins, and operational efficiency.
ArkO Corp. (ARKOW)
High-octane micro-cap; short-term momentum and low float create extreme volatility.
BHP Stock
Tech-linked metals exposure (copper, nickel) with stable cash flow and growth potential. Dividend ~3.6%, strong fundamentals.
Super Micro Computer (SMCI)
High-performance AI servers for data centers; growth driven by GPU demand.
Lightbridge (LTBR)
Advanced nuclear fuel tech. Potential upside through licensing and clean energy growth.
Root, Inc. (NASDAQ: ROOT)
Data-driven auto insurance leveraging real-time driving data. Scalable tech-driven model.
Dave Inc. (DAVE)
Fintech for underbanked users. Early access to paychecks and budgeting tools.
GeneDx Holdings (WGS)
Genomic diagnostics for rare diseases. Expanding footprint and high-potential biotech.
SoundHound AI (SOUN)
Voice-AI platform for multiple industries. 90% YoY revenue growth.
LeMaitre Vascular (LMAT)
Medical devices for vascular disease. Steady revenue and global expansion.
Tuya Inc. (TUYA)
IoT platform enabling connected devices globally. Cloud and AI solutions drive growth.
ChargePoint Holdings (CHPT)
EV charging network in North America and Europe. Benefiting from EV adoption.
MercadoLibre (MELI)
Latin America e-commerce and fintech leader. Logistics and digital payments growth.
IREN Limited (IREN)
AI cloud and HPC infrastructure, formerly a Bitcoin mining operator. Multi-dimensional tech play.
Viking Therapeutics (NASDAQ: VKTX)
Clinical-stage biotech for metabolic and endocrine therapies. Strong cash position, high-risk pipeline.
Lululemon (LULU)
Premium retail brand with loyal customer base. Strong margins and $1B stock buyback.
Symbotic (SYM)
Warehouse automation and robotics solutions. High-growth exposure to e-commerce and logistics.
Sarepta Therapeutics (SRPT)
Gene therapy for neuromuscular diseases. Catalyst-heavy biotech stock.
CRISPR Therapeutics AG (NASDAQ: CRSP)
Gene-editing therapies using CRISPR/Cas9. High-growth but volatile biotech play.
Rubrik, Inc (NYSE: RBRK)
Cloud/SaaS backup and cyber-recovery solutions. Strong growth potential with recurring revenue.
Kraken Robotics Inc (CVE: PNG)
Advanced underwater robotics, sonar, LiDAR, and subsea batteries. Turnkey Robotics-as-a-Service.
Pacific Biosciences of California (PACB)
HiFi long-read genome sequencing. Operational efficiency improving despite mixed revenue.
Stantec (STN)
Canadian infrastructure projects. Record backlog and consistent revenue growth.
Wealth Minerals Ltd. (TSXV: WML)
Lithium exploration in South America. Speculative early-stage exposure to battery metals.
Datadog Inc. (DDOG)
Cloud monitoring and observability SaaS. 26% YoY revenue growth; strong AI monitoring play.
Alpha Modus Holdings Inc. (AMOD)
AI-powered analytics and fintech solutions. High-risk, high-growth potential.
LifeStance Health Group, Inc. (LFST)
Tele-mental health services in the U.S. Strong expansion and 16–17% revenue growth.
Appian Corporation (APPN)
Low-code automation for enterprises. Moderate growth, strong market presence.
FuboTV (FUBO)
Sports-focused streaming. Growing subscriptions but unprofitable.
USA Rare Earth (USAR)
Integrated U.S. rare-earth supply chain. High-potential but pre-revenue.
Eos Energy Enterprises (EOSE)
Zinc-based long-duration battery systems. Large pipeline, high capital needs.
Globalstar (GSAT)
Mobile satellite services and IoT/5G. High-risk, high-reward growth.
Navitas Semiconductor (NVTS)
GaN and SiC semiconductors for EV, solar, and data centers. High valuation but strong design wins.
Intuitive Machines (LUNR)
Lunar economy focus. Strong backlog but high risk due to lack of profitability.
AST SpaceMobile (ASTS)
Satellite-to-smartphone connectivity. Huge upside potential, extreme valuation risk.
Datavault AI Inc. (DVLT)
Data monetization and AI platform. 467% Q2 2025 growth; high-potential AI play.
American Bitcoin Corp. (ABTC)
Bitcoin mining and AI data center power. Volatile but potentially undervalued early-stage AI play.
Draganfly Inc.
Canadian UAV/drone manufacturer with diversified applications.
Las Vegas Sands Corp. (LVS)
Global gaming resort operator. Strong revenue base.
Aurora Innovation (AUR)
Autonomous trucking company with Aurora Driver. Industry-backed growth.
Clear Secure Inc. (YOU)
Biometric security and identity solutions. Subscription-based model.
Acelyrin Inc. (SLRN)
Clinical-stage biotech for immune and rare diseases. High upside potential.
Bitfarms Ltd. (BITF)
Bitcoin miner expanding into AI/HPC infrastructure.